BioCorRx Inc.

BICX · OTC Markets OTCID · Stock · Healthcare
$0.25
+0.00% today
Delayed price,

What BioCorRx does

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss management program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$7.4M
P/E (ttm)
—
Forward P/E
-3.6
Dividend yield
0.00%
Beta
0.21
Profit margin
0.0%
Employees
—
Headquarters
Anaheim, CA, United States
Exchange
OTC Markets OTCID

Performance

1 Month
+10.6%
3 Months
-15.0%
6 Months
-18.0%
1 Year
-37.5%
5 Years
-94.6%
$0.1552-week range$1.28
Biggest setback — last 12 months
-69.3%
11 May 2026 → 10 Aug 2026
Fell from $0.50 to $0.15 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+94.1%
2 Mar 2026 → 11 May 2026
Ran from $0.26 to $0.50 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$0.16 (-35.2%)$0.25$0.39 (+54.2%)
3 Months$0.12 (-52.8%)$0.25$0.53 (+111.7%)
6 Months$0.09 (-65.4%)$0.25$0.72 (+188.8%)
12 Months$0.06 (-77.7%)$0.25$1.12 (+348.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 150.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent insider activity

Acquired 1,889,124 shares — Lucido Louis C., President · 2025-01-31
Acquired 752,979 shares — Felix Lourdes, CEO and CFO · 2025-01-31
Acquired 44,220 shares — Lucido Louis C., President · 2024-07-10
Acquired 15,770 shares — Ingargiola Luisa, Director · 2024-07-08
Acquired 10,204 shares — Felix Lourdes, CEO and CFO · 2024-07-08
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.